BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7334086)

  • 1. Intrathecal synthesis of antibodies to diphtheria and tetanus toxoids in multiple sclerosis patients.
    Salmi A; Viljanen M; Reunanen M
    J Neuroimmunol; 1981 Sep; 1(3):333-41. PubMed ID: 7334086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum titers of IgG antibodies against tetanus and diphtheria toxoids and risk of multiple sclerosis.
    Massa J; Munger KL; O'Reilly EJ; Levin LI; Ascherio A
    J Neuroimmunol; 2009 Mar; 208(1-2):141-2. PubMed ID: 19201486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody response after vaccination with tetanus and diphtheria toxoids in human T-cell lymphotropic virus type 1 asymptomatic carriers.
    Biasutti C; Moraes-Pinto MI; Segurado AC
    Vaccine; 2008 Jun; 26(23):2808-10. PubMed ID: 18455282
    [No Abstract]   [Full Text] [Related]  

  • 4. IgG and IgG subclass specific antibody responses to diphtheria and tetanus toxoids in newborns and infants given DTP immunization.
    Dengrove J; Lee EJ; Heiner DC; St Geme JW; Leake R; Baraff LJ; Ward JI
    Pediatr Res; 1986 Aug; 20(8):735-9. PubMed ID: 3737285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced immunogenicity of diphtheria and tetanus toxoids when combined with pertussis toxoid.
    Trollfors B; Taranger J; Lagergård T; Sundh V
    Pediatr Infect Dis J; 2005 Jan; 24(1):85-6. PubMed ID: 15665717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody levels to diphtheria, tetanus, and rubella in infants vaccinated while on PD: a Study of the Pediatric Peritoneal Dialysis Study Consortium.
    Neu AM; Warady BA; Furth SL; Lederman HM; Fivush BA
    Adv Perit Dial; 1997; 13():297-9. PubMed ID: 9440877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negatively charged liposomes as immunological adjuvant for tetanus and diphtheria toxoids.
    Popescu C; Durbaca S; Ivanov D
    Roum Arch Microbiol Immunol; 1998; 57(3-4):255-61. PubMed ID: 11845437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acellular pertussis vaccine: immunogenicity and safety of an acellular pertussis vs. a whole cell pertussis vaccine combined with diphtheria and tetanus toxoids as a booster in 18- to 24-month old children.
    Pichichero ME; Badgett JT; Rodgers GC; McLinn S; Trevino-Scatterday B; Nelson JD
    Pediatr Infect Dis J; 1987 Apr; 6(4):352-63. PubMed ID: 3495775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of IRIV- versus alum-adjuvanted diphtheria and tetanus toxoid vaccines in influenza primed mice.
    Zurbriggen R; Glück R
    Vaccine; 1999 Mar; 17(11-12):1301-5. PubMed ID: 10195764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative estimation of diphtheria and tetanus toxoids. 4. Toxoids as international reference materials defining Lf-units for diphtheria and tetanus toxoids.
    Lyng J
    Biologicals; 1990 Jan; 18(1):11-7. PubMed ID: 2317349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acellular pertussis vaccine booster combined with diphtheria and tetanus toxoids for adolescents.
    Pichichero ME; Blatter MM; Kennedy WA; Hedrick J; Descamps D; Friedland LR
    Pediatrics; 2006 Apr; 117(4):1084-93. PubMed ID: 16585302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Booster response to the tetanus and diphtheria toxoid carriers of 11-valent pneumococcal conjugate vaccine in adults and toddlers.
    Olander RM; Wuorimaa T; Käyhty H; Leroy O; Dagan R; Eskola J
    Vaccine; 2001 Nov; 20(3-4):336-41. PubMed ID: 11672895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of a three-component acellular pertussis vaccine with a whole-cell pertussis vaccine in 15- through 20-month-old infants.
    Bernstein HH; Rothstein EP; Reisinger KS; Blatter MM; Arbeter AM; Fontana ME; Jacobs JM; Long SS; Rathfon H; Crayne O
    Pediatrics; 1994 Apr; 93(4):656-9. PubMed ID: 8134224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyspecific human and murine antibodies to diphtheria and tetanus toxoids and phospholipids.
    Sutjita M; Hohmann A; Comacchio R; Bradley J
    Clin Exp Immunol; 1988 Aug; 73(2):191-7. PubMed ID: 3263226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Monthly dynamics of the antitoxic immunity against diphtheria and tetanus and of normal antibodies to fraction I of the plague microbe in adults].
    Basova NN; Kravtsov FE; Naumovich LS
    Zh Mikrobiol Epidemiol Immunobiol; 1982 Mar; (3):82-6. PubMed ID: 6211009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 5-year follow-up on antibody response after diphtheria and tetanus vaccination in hemodialysis patients.
    Krüger S; Müller-Steinhardt M; Kirchner H; Kreft B
    Am J Kidney Dis; 2001 Dec; 38(6):1264-70. PubMed ID: 11728959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific antibody responses to diphtheria/tetanus revaccination in children evaluated for immunodeficiency.
    McCusker C; Somerville W; Grey V; Mazer B
    Ann Allergy Asthma Immunol; 1997 Aug; 79(2):145-50. PubMed ID: 9291419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diphtheria, tetanus, pertussis: antibody detection in New Zealand.
    Lau RC
    N Z Med J; 1987 Aug; 100(829):481-3. PubMed ID: 3502676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of neonatal immunization with diphtheria and tetanus toxoids on antibody responses to Haemophilus influenzae type b conjugate vaccines.
    Lieberman JM; Greenberg DP; Wong VK; Partridge S; Chang SJ; Chiu CY; Ward JI
    J Pediatr; 1995 Feb; 126(2):198-205. PubMed ID: 7844665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnitude of interference after diphtheria-tetanus toxoids-acellular pertussis/Haemophilus influenzae type b capsular polysaccharide-tetanus vaccination is related to the number of doses administered.
    Daum RS; Zenko CE; Given GZ; Ballanco GA; Parikh H; Germino K
    J Infect Dis; 2001 Nov; 184(10):1293-9. PubMed ID: 11679918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.